Buspirone Hydrochloride Tabs USP 10 mg — Class III drug recall D-0113-2024
Terminated recall by NCS Healthcare of Kentucky Inc, reported 2023-11-29, distributed nationwide. Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recal
| Recall number | D-0113-2024 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | NCS Healthcare of Kentucky Inc, Glasgow, KY, United States |
| Recall initiated | 2023-10-27 |
| Classified | 2023-11-21 |
| Reported by FDA | 2023-11-29 |
| Terminated | 2024-07-14 |
| Distributed | Nationwide (US) |
| Quantity | 1,344 cards |
| NDC | 00615-7689, 00615-7689-05, 00615-7689-31, 00615-7689-39, 00615-7714, 00615-7714-05, 00615-7714-30, 00615-7714-39, 00615-7718, 00615-7718-05, 00615-7718-28, 00615-7718-31, 00615-7718-39 |
| Expiration dates | 2024-08-31 |
Product
Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-count blister card (NDC 0615-7718-39), Rx only, Mfd By Pliva HRVATSKA for Teva USA, PKG by Vangard Glasgow, KY 42141.
Reason for recall
Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0113-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.